CAR-T Cell Therapy in Aggressive Lymphoma | HOPPE CME Conference

Join us for an insightful CME session on “CAR-T Cell Therapy in Aggressive Lymphoma: Current Indications and Future Paradigm” presented by M. Bilal Abid, MD, MS. This talk was delivered during the CME Sessions at the HOPPE Inaugural Conference & Vision Summit, held at Houston Marriott Sugar Land, April 10–12, 2026. Dr. Abid discusses the current role of CAR-T cell therapy in aggressive lymphoma, including patient selection, approved indications, treatment considerations, response assessment, toxicity management, and emerging future directions that may shape the next era of lymphoma care. This educational session is intended for physicians, trainees, hematology and oncology professionals, researchers, and anyone interested in advances in cellular therapy and lymphoma treatment. Speaker: M. Bilal Abid, MD, MS Event: HOPPE Inaugural Conference & Vision Summit Venue: Houston Marriott Sugar Land Dates: April 10–12, 2026 #HOPPE #CARTCellTherapy #Lymphoma #AggressiveLymphoma #CellularTherapy #Hematology #Oncology #CancerCare #CME #MedicalEducation